Nautilus Biotechnology Inc reports results for the quarter ended in December - Earnings Summary

Nautilus Biotechnology

23/02/2023 14:32

* Nautilus Biotechnology Inc  NAUT.OQ  reported a quarterly
adjusted loss of 11 cents​​ per share for the quarter ended in
December. The mean expectation of four analysts for the quarter
was for a loss of 15 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Nautilus Biotechnology Inc's reported EPS for the quarter
was a
loss of 11 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Nautilus Biotechnology Inc shares had risen by 11.1% this
quarter.
    * The company reported a quarterly loss of $13.41 million.
    * Wall Street's median 12-month price target for Nautilus
Biotechnology Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
23 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.15          -0.11          Beat
 Sep. 30 2022      -0.15          -0.11          Beat
 Jun. 30 2022      -0.17          -0.12          Beat
 Mar. 31 2022      -0.16          -0.13          Beat